Birnbaum F, Reis A, Reinhard T
Universitätsaugenklinik Freiburg, 79106, Freiburg.
Ophthalmologe. 2007 May;104(5):381-7. doi: 10.1007/s00347-007-1516-y.
Topical steroids are routinely used in the postoperative treatment following penetrating keratoplasty. Due to the known side effects such as steroid-response glaucoma, cataract, and surface disorders, a broader armamentarium of topical immunomodulating drugs with comparable efficacy, better tolerance and less side effects is desirable. Cyclosporine A and FK506 eye drops are a promising alternative. A new approach involves subconjunctival drug delivering implants and locally applied antiangiogenic substances, which still have to be tested in clinical studies.
局部用类固醇常用于穿透性角膜移植术后的治疗。鉴于已知的副作用,如类固醇反应性青光眼、白内障和表面疾病,需要有一系列更广泛的局部免疫调节药物,它们具有相当的疗效、更好的耐受性和更少的副作用。环孢素A和FK506滴眼液是一种有前景的替代药物。一种新方法涉及结膜下给药植入物和局部应用抗血管生成物质,这些仍有待在临床研究中进行测试。